Search Results

5476 - 5500 of 104030
TitleWireDateTime
Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis Globe Newswire 10/07 08:00
Esperion Reaches Settlement Agreement with Sixth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040 Globe Newswire 10/07 08:00
Melissa Introduces Elected Officials Data for More Effective Government Relations and Advocacy Globe Newswire 10/07 08:00
Virtu Financial to Host Conference Call Announcing Third Quarter 2026 Results on Thursday, November 5, 2026 Globe Newswire 10/07 08:00
Bitcoin Learns to Move: IBVM Lists on MEXC as TOKEN2049 Comes to Singapore Globe Newswire 10/07 07:55
Mobilicom to Unveil New Solution and Showcase Cybersecure Portfolio at AUSA 2026; Company to Present at ThinkEquity Investor Conference Globe Newswire 10/07 07:45
Interpol crackdown on illegal mining, logging and wildlife trafficking leads to 233 arrests AP Online 10/07 07:33
Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud Globe Newswire 10/07 07:32
Atlantic HPC Group Inc Appoints Leo Lin as Chief Executive Officer Globe Newswire 10/07 07:30
Volatus Aerospace Completes the Initial ISR Drone Fleet Delivery to NATO Partner Globe Newswire 10/07 07:30
Beam Global Signs Definitive Agreement to Acquire Drone Technology Company ScoutDI, Creating a Vertically Integrated U.S. Drone Platform for Industrial and Defense Markets Globe Newswire 10/07 07:30
Sportradar Announces Agreement for the Divestiture of Coaching and Scouting Business of Synergy Sports to Teamworks Innovations Globe Newswire 10/07 07:30
Crane NXT Appoints Jeong H. Kim to Board of Directors Globe Newswire 10/07 07:30
Hillman Sets Third Quarter 2026 Earnings Release and Results Presentation Date Globe Newswire 10/07 07:30
CHARM Therapeutics announces first patient dosed and first cohort fully enrolled in its Phase I/II clinical trial of CHM-029 for Acute Myeloid Leukemia Globe Newswire 10/07 07:08
Gilat Secures Over $10 Million in Additional SkyEdge IV Orders from a Leading Satellite Operator Globe Newswire 10/07 07:05
Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026 Globe Newswire 10/07 07:05
Lantronix CEO to Meet with Investors and Defense Customers at AUSA 2026 Globe Newswire 10/07 07:05
Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026 Globe Newswire 10/07 07:05
Q2 Metals Extends Near Surface Mineralization 100 Metres North at the Cisco Lithium Project, Intercepting 134.5 Metres at 1.20% Li₂O and 101.6 Metres at 1.02% Li₂O Globe Newswire 10/07 07:00
VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy Globe Newswire 10/07 07:00
BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds Globe Newswire 10/07 07:00
Noah Closes $38m Seed Funding Round as Major Enterprises Move Cross-Border Payments onto Stablecoin Globe Newswire 10/07 07:00
Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics Globe Newswire 10/07 07:00
Marex announces changes to Group Board Globe Newswire 10/07 07:00
5476 - 5500 of 104030

News, Photo and Web Search

Search News by Ticker